126 related articles for article (PubMed ID: 29625213)
21. Pharmacokinetics and Skin Tolerability of Intracutaneous Zolmitriptan Delivery in Swine Using Adhesive Dermally Applied Microarray.
Nguyen J; Lewis H; Queja A; Diep AN; Hochart G; Ameri M
J Pharm Sci; 2018 Aug; 107(8):2192-2197. PubMed ID: 29772224
[TBL] [Abstract][Full Text] [Related]
22. Probing the role of chemical enhancers in facilitating drug release from patches: Mechanistic insights based on FT-IR spectroscopy, molecular modeling and thermal analysis.
Song W; Quan P; Li S; Liu C; Lv S; Zhao Y; Fang L
J Control Release; 2016 Apr; 227():13-22. PubMed ID: 26896738
[TBL] [Abstract][Full Text] [Related]
23. Design of a tulobuterol patch with improved mechanical properties: effect of transdermal permeation enhancers on the release process of metal ligand-based acrylic pressure-sensitive adhesives.
Nan L; Song H; Wang H; Mi R; Wang X; Fang L
Drug Deliv Transl Res; 2024 Mar; 14(3):802-811. PubMed ID: 38082031
[TBL] [Abstract][Full Text] [Related]
24. Development of a drug-in-adhesive patch combining ion pair and chemical enhancer strategy for transdermal delivery of zaltoprofen: pharmacokinetic, pharmacodynamic and in vitro/in vivo correlation evaluation.
Cui H; Quan P; Zhou Z; Fang L
Drug Deliv; 2016 Nov; 23(9):3461-3470. PubMed ID: 27257038
[TBL] [Abstract][Full Text] [Related]
25. Investigation on the effect of deep eutectic formation on drug-polymer miscibility and skin permeability of rotigotine drug-in-adhesive patch.
Liu C; Qu X; Song L; Shang R; Wan X; Fang L
Int J Pharm; 2020 Jan; 574():118852. PubMed ID: 31759103
[TBL] [Abstract][Full Text] [Related]
26. A strong, silk protein-inspired tissue adhesive with an enhanced drug release mechanism for transdermal drug delivery.
Song H; Wang L; Wu J; Liu J; Liu C; Guo J; Fang L
Acta Biomater; 2024 Jun; 181():133-145. PubMed ID: 38641185
[TBL] [Abstract][Full Text] [Related]
27. Lidocaine self-sacrificially improves the skin permeation of the acidic and poorly water-soluble drug etodolac via its transformation into an ionic liquid.
Miwa Y; Hamamoto H; Ishida T
Eur J Pharm Biopharm; 2016 May; 102():92-100. PubMed ID: 26945484
[TBL] [Abstract][Full Text] [Related]
28. Controlled transdermal delivery of fentanyl: characterizations of pressure-sensitive adhesives for matrix patch design.
Roy SD; Gutierrez M; Flynn GL; Cleary GW
J Pharm Sci; 1996 May; 85(5):491-5. PubMed ID: 8742940
[TBL] [Abstract][Full Text] [Related]
29. Development of transdermal therapeutic formulation of CNS5161, a novel N-methyl-D-aspartate receptor antagonist, by utilizing pressure-sensitive adhesives I.
Naruse M; Ogawara K; Kimura T; Konishi R; Higaki K
Biol Pharm Bull; 2012; 35(3):321-8. PubMed ID: 22382317
[TBL] [Abstract][Full Text] [Related]
30. Role of pressure-sensitive adhesives in transdermal drug delivery systems.
Lobo S; Sachdeva S; Goswami T
Ther Deliv; 2016; 7(1):33-48. PubMed ID: 26652621
[TBL] [Abstract][Full Text] [Related]
31. A novel transdermal drug delivery system based on self-adhesive Janus nanofibrous film with high breathability and monodirectional water-penetration.
Shi Y; Li Y; Wu J; Wang W; Dong A; Zhang J
J Biomater Sci Polym Ed; 2014; 25(7):713-28. PubMed ID: 24641249
[TBL] [Abstract][Full Text] [Related]
32. A polyethylene glycol-grafted pullulan polysaccharide adhesive improves drug loading capacity and release efficiency.
Song H; Nan L; Wang J; Cai Y; Sun P; Liu J; Liu C; Fang L
Int J Biol Macromol; 2024 Apr; 265(Pt 2):130958. PubMed ID: 38503369
[TBL] [Abstract][Full Text] [Related]
33. In vivo enhancement of transdermal absorption of ketotifen by supersaturation generated by amorphous form of the drug.
Inoue K; Sugibayashi K
Eur J Pharm Sci; 2012 Aug; 47(1):228-34. PubMed ID: 22728431
[TBL] [Abstract][Full Text] [Related]
34. Interaction between drugs and pressure-sensitive adhesives in transdermal therapeutic systems.
Kokubo T; Sugibayashi K; Morimoto Y
Pharm Res; 1994 Jan; 11(1):104-7. PubMed ID: 8140038
[TBL] [Abstract][Full Text] [Related]
35. Formulation optimization of a drug in adhesive transdermal analgesic patch.
Ravula R; Herwadkar AK; Abla MJ; Little J; Banga AK
Drug Dev Ind Pharm; 2016; 42(6):862-70. PubMed ID: 26288995
[TBL] [Abstract][Full Text] [Related]
36. Development of a daphnetin transdermal patch using chemical enhancer strategy: insights of the enhancement effect of Transcutol P and the assessment of pharmacodynamics.
Shen M; Liu C; Wan X; Farah N; Fang L
Drug Dev Ind Pharm; 2018 Oct; 44(10):1642-1649. PubMed ID: 29851521
[TBL] [Abstract][Full Text] [Related]
37. Quantitative evaluation of adhesive properties and drug-adhesive interactions for transdermal drug delivery formulations using linear solvation energy relationships.
Li J; Masso JJ; Rendon S
J Control Release; 2002 Jul; 82(1):1-16. PubMed ID: 12106972
[TBL] [Abstract][Full Text] [Related]
38. Controlled release in transdermal pressure sensitive adhesives using organosilicate nanocomposites.
Shaikh S; Birdi A; Qutubuddin S; Lakatosh E; Baskaran H
Ann Biomed Eng; 2007 Dec; 35(12):2130-7. PubMed ID: 17786555
[TBL] [Abstract][Full Text] [Related]
39. Design of a Drug-in-Adhesive Transdermal Patch for Risperidone: Effect of Drug-Additive Interactions on the Crystallization Inhibition and In Vitro/In Vivo Correlation Study.
Weng W; Quan P; Liu C; Zhao H; Fang L
J Pharm Sci; 2016 Oct; 105(10):3153-3161. PubMed ID: 27522527
[TBL] [Abstract][Full Text] [Related]
40. Investigations on the viscoelastic performance of pressure sensitive adhesives in drug-in-adhesive type transdermal films.
Wolff HM; Irsan ; Dodou K
Pharm Res; 2014 Aug; 31(8):2186-202. PubMed ID: 24599801
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
